Shanghai BDgene Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2018)

Organization Overview

First Clinical Trial
2020
NCT04560790
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai BDgene Co., Ltd.